Pharmacological hypomethylation is linked to drug-induced lupus pathogenesis [84], as evidenced by genome-wide hypomethylation in SLE CD4+ T cells, particularly at interferon-regulated loci, establishing an epigenetic basis for autoimmune dysregulation [85]. This evidence concerns the gene CD4 and systemic lupus erythematosus.